Pecos Hotels & Pubs approves related party transaction with GSK
- Pecos Hotels & Pubs Limited approved a related party transaction with GSK Enterprises Private Limited
- The Board meeting took place on September 30, 2026, from 2:00 pm to 3:00 pm
- Disclosure made under SEBI (LODR) Regulations, 2015, Regulation 30
- Meeting held at the Corporate Office in Bengaluru

*this image is generated using AI for illustrative purposes only.
Pecos Hotels & Pubs Limited approved a related party transaction with GSK Enterprises Private Limited during its Board of Directors meeting held on September 30, 2026.
The approval was granted at the fifth Board meeting of the fiscal year 2026-27. The session commenced at 2:00 pm and concluded at 3:00 pm at the company's corporate office in Bengaluru. This disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency for stakeholders regarding transactions involving related entities.
Meeting details and governance
The Board of Directors convened to consider and approve the specific transaction terms between the listed entity and GSK Enterprises Private Limited. The meeting was conducted physically at the Corporate Office located at Guardian House, Infantry Road, Bengaluru. Neelam Kumari, serving as the Company Secretary and Compliance Officer, signed off on the intimation submitted to the Bombay Stock Exchange (SME Listed).
| Detail | Information |
|---|---|
| Meeting Date | September 30, 2026 |
| Time | 2:00 pm to 3:00 pm |
| Counterparty | GSK Enterprises Private Limited |
| Regulatory Basis | SEBI LODR Regulation 30 |
No financial values or specific terms of the transaction were disclosed in the immediate filing. The company remains compliant with listing obligations by reporting the occurrence of the related party transaction promptly.
Historical Stock Returns for Pecos Hotels & Pubs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +5.93% | 0.0% | 0.0% | -41.08% | +429.50% |
What specific financial terms and valuation metrics will be disclosed in the upcoming quarterly filings regarding the transaction with GSK Enterprises Private Limited?
How might this related party transaction influence Pecos Hotels & Pubs Limited's liquidity position and capital allocation strategy for the remainder of FY2026-27?
Will the increased frequency of related party transactions trigger heightened scrutiny from SEBI or require additional shareholder approvals in future board meetings?


































